BioCorRx Inc. (OTCMKTS:BICX – Get Free Report) passed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $0.34 and traded as low as $0.30. BioCorRx shares last traded at $0.30, with a volume of 162 shares.
BioCorRx Price Performance
The stock’s fifty day moving average is $0.34 and its 200-day moving average is $0.58. The stock has a market capitalization of $2.93 million, a PE ratio of -0.65 and a beta of 0.60.
BioCorRx (OTCMKTS:BICX – Get Free Report) last announced its quarterly earnings results on Tuesday, August 13th. The company reported ($0.13) earnings per share (EPS) for the quarter.
BioCorRx Company Profile
BioCorRx Inc, through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition.
Featured Articles
- Five stocks we like better than BioCorRx
- Investing in the High PE Growth Stocks
- Analysts Predict New Highs for Cybersecurity Stock by Christmas
- Stock Analyst Ratings and Canadian Analyst Ratings
- Nuclear Power Reaches Critical Mass: Top Stocks to Watch Now
- Dividend Capture Strategy: What You Need to Know
- 2 Energy Stocks Surging on Billion-Dollar DOE Loan Commitments
Receive News & Ratings for BioCorRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioCorRx and related companies with MarketBeat.com's FREE daily email newsletter.
